Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Nasopharyngeal carcinoma
CUI: C2931822
Disease: Nasopharyngeal carcinoma
320 0.882 0.160 6 31295974 intron variant T/C snv 0.20 0.720 1.000 3 2010 2018
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
526 0.882 0.160 6 31295974 intron variant T/C snv 0.20 0.700 1.000 2 2009 2010
AIDS, PROGRESSION TO
CUI: C1836233
Disease: AIDS, PROGRESSION TO
526 0.882 0.160 6 31295974 intron variant T/C snv 0.20 0.700 1.000 2 2009 2010
HIV-1, RESISTANCE TO
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
526 0.882 0.160 6 31295974 intron variant T/C snv 0.20 0.700 1.000 2 2009 2010
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
527 0.882 0.160 6 31295974 intron variant T/C snv 0.20 0.700 1.000 2 2009 2010
Nasopharyngeal Neoplasms
CUI: C0027439
Disease: Nasopharyngeal Neoplasms
36 0.882 0.160 6 31295974 intron variant T/C snv 0.20 0.700 1.000 2 2010 2016
Acquired Immunodeficiency Syndrome
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
42 0.882 0.160 6 31295974 intron variant T/C snv 0.20 0.700 1.000 1 2009 2009
Psoriasis
CUI: C0033860
Disease: Psoriasis
705 0.882 0.160 6 31295974 intron variant T/C snv 0.20 0.010 1.000 1 2018 2018